TGFB1 and neoplasm: In the tumor stromal remodeling panel (Figure 7i), Y332D significantly decreased the scores of TGF‐β signaling, EMT, ECM, and VEGF pathway signatures compared to the vehicle, while RT showed a trend toward increasing these scores versus the vehicle.